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Nanoceria Distribution and Effects are Mouse-strain Dependent
Abstract
Prior studies showed nanoparticle clearance was different in C57BL/6 vs BALB/c mice, strains prone to
Th1 and Th2 immune responses, respectively. Objective: Assess nanoceria (cerium oxide, CeO2
nanoparticle) uptake time course and organ distribution, cellular and oxidative stress , and bioprocessing
as a function of mouse strain. Methods: C57BL/6 and BALB/c female mice were i.p. injected with 10
mg/kg nanoceria or vehicle and terminated 0.5 to 24 h later. Organs were collected for cerium analysis;
light and electron microscopy with elemental mapping; and protein carbonyl, IL-1β, and caspase-1
determination. Results: Peripheral organ cerium significantly increased, generally more in C57BL/6
mice. Caspase-1 was significantly elevated in the liver at 6 h, to a greater extent in BALB/c mice,
suggesting inflammasome pathway activation. Light microscopy revealed greater liver vacuolation in
C57BL/6 mice and a nanoceria-induced decrease in BALB/c but not C57BL/6 mice vacuolation.
Nanoceria increased spleen lymphoid white pulp cell density in BALB/c but not C57BL/6 mice. Electron
microscopy showed intracellular nanoceria particles bioprocessed to form crystalline cerium phosphate
nanoneedles. Ferritin accumulation was greatly increased proximal to the nanoceria, forming core-shelllike structures in C57BL/6 but even distribution in BALB/c mice. Conclusions: BALB/c mice were more
responsive to nanoceria-induced effects, e.g., liver caspase-1 activation, reduced liver vacuolation, and
increased spleen cell density. Nanoceria uptake, initiation of bioprocessing, and crystalline cerium
phosphate nanoneedle formation were rapid. Ferritin greatly increased with a macrophage phenotypedependent distribution. Further study will be needed to understand the mechanisms underlying the
observed differences.

Key words: BALB/c mice; caspase-1; C57BL/6 mice; ferritin; liver; nanoceria
Word count: ~ 5675
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Introduction
Nanoparticles (NPs) are cleared by the mononuclear phagocytic system. Differences in
immunological reactivity contribute to varying sensitivity to pathogenic agents, tumor growth,
and autoimmune diseases. Acquired immunity, a specific and powerful response to pathogens, is
classified into Th1 and Th2 responses. C57BL/6 and BALB/c mice are prototypical Th1- and
Th2-type mouse strains, respectively, based on their cytokine secretion patterns. T cells from
C57BL/6 mice preferentially produce Th1 cytokines with high interferon-γ (IFNγ) and low
interleukin (IL-4) levels, whereas those from BALB/c mice favor Th2 cytokine production with
low IFNγ and high IL-4 levels. These two mice strains have been extensively studied to evaluate
the dependence of pathological processes on genetically determined characteristics of the
immune system. C57BL/6 and BALB/c mice have been shown to respond differently to
infectious agents (Fornefett et al. 2018); ischemia-induced retinal injury (Shi et al. 2018);
antipyrine, vitamin A, and monoamine metabolism (Goverse et al. 2015; Seredenin et al. 1990;
Seredenin et al. 2000); and morphine (Di Francesco et al. 1998). Immune status differentially
affected 300 nm PEG hydrogel and 30 nm carboxylate-coated quantum dot NP clearance in
female C57BL/6 and BALB/c mice (Jones et al. 2013).

Nanoceria (nanoscale cerium oxide, cerium dioxide, ceria, CeO2) is a family of metal oxide
engineered nanomaterials extensively used industrially and shown to have beneficial
pharmaceutical properties. Nanoceria are auto-catalytically redox active, cycling between Ce+++
and Ce++++ (Deshpande et al. 2005). The surface has oxygen vacancies in its cubic fluorite
structure that allow it to easily accept and donate oxygen, providing its catalytic properties.
Nanoceria are used as catalysts in diesel fuel, abrasives in chemical mechanical planarization in
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integrated circuit manufacture, as structural supports for catalysts for fuel synthesis applications,
in solid oxide fuel cells, and in rechargeable batteries (Feng et al. 2006; Younis et al. 2016).
Cerium oxide was selected by the Organisation for Economic Co-operation and Development
(OECD) Working Party on Manufactured Nanomaterials as one of 13 representative
manufactured nanomaterials for safety testing (OECD 2010).

Nanoceria have been demonstrated to have therapeutic potential for multiple conditions with an
oxidative stress/inflammation component including cancer, radiation damage, bacterial infection,
sepsis, wounds, stroke-induced ischemia, retinal degeneration, and neurodegenerative diseases
(Dhall and Self 2018). Additional applications are cited in the introduction of Yokel et al (Yokel
et al. 2019a). Nanoceria have shown utility as nanozymes in sensors for biomolecular
recognition (Singh 2016).

Greater NP uptake by M1- or M2-like cells, the cell counterpart to Th1- and Th2-type animals,
has not been consistently reported. Uptake of ~ 200 nm mesoporous silica particles by
macrophage colony-stimulating factor-stimulated macrophages (macrophages polarized toward
the M2 phenotype) was ~ 3-fold greater than uptake by granulocyte macrophage colonystimulating factor-stimulated human monocyte-derived macrophages (macrophages polarized
toward the M1 phenotype) (Gallud et al. 2017). Human macrophage uptake of 26 and 41 nm
silica particles by M2-like cells was 224 and 166%, respectively, of that by M1-like cells
(Hoppstädter et al. 2015). Uptake of 15 nm gold particles by M1- and M2-like human
macrophages was comparable (0.8 and 0.7%), but greater by M2- than M1-like cells for 60 (79
and 72%) and 100 nm (95 and 88%) particles (MacParland et al. 2017). M2-like primary human
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Kupffer cells also took up more 100 nm particles than M1-like cells (MacParland et al. 2017). In
contrast, murine macrophages polarized to the M1 phenotype took up > 3-fold more 130 nm
silica particles than M2 cells (Herd et al. 2015). There was no difference in ~ 100 nm polymer
NP uptake by C57BL/6 bone marrow derived macrophages that were polarized to M1 or M2
phenotypes or M1 and M2 macrophages harvested from bronchoalveolar lavage fluid of
C57BL/6 mice after induction of Th1 or Th2 microenvironments in the lung (McDaniel et al.
2017). Nanoceria is bioprocessed after cell uptake (Graham et al. 2017; Graham et al. 2014;
Graham et al. 2018b). The effect of immune status on this process has not been reported.
The objective of the present study was to assess the influence of mouse strain on the time course
of nanoceria organ and cell uptake, cellular and oxidative stress, and bioprocessing after an acute
nanoceria exposure.

Materials and Methods
Materials
Nanoceria was synthesized using a hydrothermal method based on Masui et al. (Masui et al.
2002) that included citric acid, resulting in citrate-coated nanoceria. It was dialyzed five times
against ten volumes of iso-osmotic citric acid to remove free cerium and unincorporated
reactants. We used nanoceria prepared by this method that was previously extensively
characterized and shown to have a TEM primary particle diameter of 4.2 ± 1.2 (S.D.), an 11 nm
hydrodynamic diameter in DI water, and a zeta potential in DI water at pH 7.4 of ~ -38 mV. The
particles were hexagonal with an ~ monolayer citrate coating. Details are reported in Chapter 1
of Matthew Hancock’s dissertation (Hancock 2019). A sample of the nanoceria used in this study
was characterized to determine its size, shape, diffraction pattern, and cerium valence state, using

8

methods described in Sample Preparation and Microscopy, below. Nanoceria synthesized by this
method was extensively characterized previously. These characterizations were conducted of the
nanoceria ex vivo as typically conducted. It is not possible to extensively characterize in vivo
nanomaterials.

Animals
Forty female 7 to 8 weeks old C57BL/6 and forty BALB/c mice were i.p. injected with 10 mg/kg
nanoceria in iso-osmotic citrate at pH 7.4 or vehicle. The study utilized only females, as did the
initial study demonstrating the effect of immune status on NP clearance (Jones et al. 2013) and a
more recent study (Fornefett et al. 2018). They were studied in two groups of 20 mice of each
strain. To minimize the number of mice, enable consecutive dosing and termination of one
mouse from each strain that received the same treatment, and complete a group of 40 mice in one
week, three were assigned to each nanoceria treatment group with one control mouse at each
termination time. This created a control group for each strain of five mice. They were terminated
0.5, 1, 3, 6, or 24 h after nanoceria injection by carbon dioxide asphyxiation and decapitation.
This time frame was similar to the initial study demonstrating the effect of immune status on NP
clearance (Jones et al. 2013), is sufficient to characterize initial nanoceria uptake and distribution
(He et al. 2010; Yokel et al. 2012; Yokel et al. 2009; Yokel et al. 2014) and to see nanoceriainduced oxidative-stress-related effects (Hardas et al. 2010; Hardas et al. 2014; Ma et al. 2014;
Nemmar et al. 2017; Rice et al. 2015; Xue et al. 2013). Most importantly it includes the IL-1β
and caspase-1 response time to acute insult in cells and mice (Bulugonda et al. 2017; Lin et al.
2016; Okinaga et al. 2015) (Dinesh and Rasool 2017; O'Brien et al. 2017; Uh et al. 2017; Zheng
et al. 2017). Selected organs were weighed and collected in clean tubes for elemental analysis
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(second group), in glutaraldehyde/ paraldehyde in Sorenson’s buffer for histology (both groups),
and flash frozen for oxidative stress indicator assays (both groups). The selected organs were
those known to accumulate the majority of nanoceria after its introduction by the i.v., i.p., oral,
and pulmonary routes (Aalapati et al. 2013; Catalán et al. 2019; Geraets et al. 2012; He et al.
2010; Hirst et al. 2013; Molina et al. 2014; Park et al. 2018; Rojas et al. 2012; Yokel et al. 2012;
Yokel et al. 2009; Yokel et al. 2014).

Cerium Quantitation
Organ samples from the second group were harvested from the brain (sample site and average
weight, in mg) (right hemisphere cortex, 60), heart (apex, 30), lung (superior lobe, 40), kidney
(right, 100), spleen (dorsal, 20), and liver (right lobe, 250). Samples were digested with two:one
HNO3:H2O2 in Teflon vessels in a CEM MARS Express microwave digestion system. Terbium
was added as an internal standard. Samples were analyzed compared to standards. Cerium was
quantified by inductively coupled plasma mass spectrometry (ICP-MS) (Agilent 7500cx, Agilent
Technologies, Inc., Santa Clara, CA) (Yokel et al. 2009). The percent of the nanoceria dose in
the organ was calculated from the cerium concentration in the analyzed sample times the
mouse’s organ weight divided by its nanoceria dose times 100.

Sample Preparation and Microscopy
Sectioned liver (right lobe) and spleen (middle third) tissues from the first group were stained
with toluidine blue for light microscopy. An image from each of the 40 mice was visually
assessed for qualitative histological changes (by MTT). Each liver image was saved as a TIF file
and then opened in ImageJ. After scalebar sizing, a 2” x 2” image section was cropped from the
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5.7” x 4.7” original, changed into an 8-bit B/W image, and used for ImageJ tracing of unstained
(vacuolated) areas in two 2” x 2” sections (one from the upper left, the other from the upper right
of the image). The total area of the cropped section was also measured, which was used to
determine the percent total vacuole area of the total 2” x 2” sections. Image J endpoints
determined were the number of vacuoles; average vacuole area; sum of the vacuole area; vacuole
area as a percentage of the total vacuole area; and average perimeter, Feret, and min Feret of the
vacuoles. Each spleen image was saved as a JPEG image. Two 4.25” x 3.25” quadrants were
cropped from each original image (8.75” x 7.75”) in Windows Photo Viewer. Nuclei were
counted from each cropped section as a proxy for cell count to determine cell density. The
administered dose of nanoceria (10 mg/kg) would not be expected to produce sufficient
intracellular nanoceria agglomerations to be visible with light microscopy, as was seen after
much higher nanoceria doses (Catalán et al. 2019; Yokel et al. 2009). Light microscopy would
not enable visualization of the primary (~ 4 nm) particles. To visualize nanoceria uptake and
distribution, selected tissues from both groups were prepared unstained for transmission electron
microscopy (TEM) and scanning TEM (STEM). They were assessed by an experimenter blind
to the treatment condition (UMG). A NIOSH facilities JEOL 2100F high resolution
HRTEM/STEM operated at 200 keV with an analytic pole piece was utilized for the electron
microscopy work. Images were recorded using a Gatan Orius 830 4m CCD camera. Data
acquisition, analysis, processing for electron energy loss spectroscopy (EELS) and STEM data
were done with Gatan Inc. Digital Micrograph software. A Gatan high angle annular dark field
detector was used for STEM imaging. All STEM images were acquired using a 0.17 nm
analytical probe , while energy-dispersive spectroscopy (EDS) and EELS analyses were
performed using a 1 nm probe. A Gatan Tridiem filter was used for EELS data acquisition and an
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Oxford AZtec EDS system (Concord, MA) was used for EDS acquisition and elemental
mapping. A power law background was subtracted from core edge EELS data acquired from
select particles using an integration window of approximately 50 eV. To determine if the de novo
formed biomineralized iron NPs were ferritin-like, oxygen and iron EELS analyses were
conducted on 25 particles in liver from C57BL/6 mice and minerals that contain only Fe++
(amosite) and Fe+++ (hematite).

Oxidative Stress Indicator Assays
Brain (left hemisphere cortex), liver (left lobe), and spleen (ventral) samples from both groups
were homogenized with protease inhibitors. Tissues were homogenized with 10 to 15 strokes of a
pestle Dounce homogenizer, then diluted with 4 µg/ml leupeptin, 4 µg/ml pepstatin A, 5 µg/ml
aprotinin, and 0.2 mM PMSF in RIPA Buffer (all from Sigma). The sample was sonicated for
two ten second bursts, on ice between sonications, using a 550 Sonic Dismembrator (Fisher
Scientiﬁc). Cell debris was pelleted by centrifugation at 8,000 x g for 10 min at 4 °C.
Supernatant was removed and stored at -80 °C. Protein concentration was determined by the
bicinchoninic acid method. Protein carbonyls were determined using the OxyBlot Protein
Oxidation Detection Kit (Millipore). IL-1β and caspase-1 were determined using western
blotting. Samples were prepared as 30 to 45 μg protein/ml in a 1:1 ratio of supernatant:Laemmli
sample buffer (50 μl β-mercaptoethanol and 950 μl 2x Laemmli buffer [Bio-Rad]). They were
loaded on 8–16% Criterion™ TGX Stain-Free™ Protein Gels (Bio-Rad). The gel was run at 70
Vs for 20 min then allowed to complete migration at 120 Vs then transferred to a 0.2 μm
nitrocellulose membrane via a Bio-Rad Trans-Blot Turbo Transfer System at the pre-set Midi Gel
setting. The membrane was blocked overnight at room temperature in 5% BSA in TBS-T, then
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incubated (1:10,000 in TBS-T) with a primary antibody for two h. The blot was then washed of
excess antibody with Tris-buffered saline (0.1% Tween 20) for three five min washes and
incubated (1:10,000) with a secondary antibody for one h, and washed three times. The primary
antibodies were anti-IL-1β (Asp 296) rabbit antibody (Cell Signaling Technology) and anticaspase-1 rabbit antibody (Novus Biologicals). The secondary antibody was anti-rabbit goat
alkaline phosphatase secondary (Thermo Fisher).

Data Analysis
The percent of the cerium dose in organs of nanoceria-treated mice was compared by 2-way
ANOVA (strain and time) followed by group comparisons using least significant difference
(protected LSD) when the ANOVA was significant. A temporal effect was assessed by fitting
organ cerium concentrations using a linear or quadratic term as needed. Mouse strain differences
in liver vacuole endpoints and spleen cell density was assessed by two-tailed unpaired t-tests of
control mice results. Liver vacuolation endpoints, spleen cell density, organ weight, protein
carbonyl, IL-1β, and caspase-1 results of all treatment groups were compared by 1-way ANOVA
and Tukey's multiple comparisons tests. To assess nanoceria-induced temporal changes, tests for
linear correlation of time after nanoceria injection (from 0 to 24 h) vs the liver endpoints were
conducted. Statistical significance was accepted at p < 0.05 and the results of statistical tests
reported at the level of statistical significance.

Results
Nanoceria Physicochemical Characterization
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Analysis of a sample of the nanoceria used in this study showed ~ 4 nm primary particles as ~ 11
nm agglomerates (Figure 1 C and D). EDS showed the nanoceria to be crystalline (Figure 1E, F,
and G). EELS showed the nanoceria surface cerium to be predominantly Ce+++ (Figure 1H),
supported by increased surface defect density (Figure 1 E and G).
[Figure 1 near here]

Organ Weights and Cerium Concentration
There were no significant differences in organ weights as a function of mouse strain, nanoceria
treatment, or termination time. Nanoceria significantly increased cerium in peripheral organs,
generally to a greater extent in C57BL/6 than BALB/c mice (Figure 2). Organ cerium
significantly decreased over time in the brain from 0.5 h to all later times in both mouse strains.
There was an overall decrease in cerium in the heart, and an increase in the kidney, liver, and
spleen over time. The heart of BALB/c mice had significantly more cerium than C57BL/6 mice
at six h and the liver of C57BL/6 mice had significantly more cerium than BALB/c mice at 24 h.
Over all times there was more cerium in BALB/c than C57BL/6 kidneys and more in C57BL/6
than BALB/c mice spleens (Figure 2).
[Figure 2 near here]

Nanoceria Increased Liver Caspase-1
There were no statistically significant differences in brain protein carbonyl and IL-1β, liver or
spleen protein carbonyl, or spleen caspase-1 levels. IL-1β was undetectable in liver or spleen.
Caspase-1 was significantly elevated in the liver at 6 h, to a greater extent in BALB/c than
C57BL/6 mice (Figure 3) suggesting inflammasome pathway activation.
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[Figure 3 near here]

Liver and Spleen Light Microscopic Differences
Supplemental Figures 1 and 2 contain light microscopic images of toluidine blue stained liver
and spleen from mice that illustrate and were used to determine the below and Table 1 results.
Light microscopy revealed greater vacuolation in C57BL/6 than BALB/c mice liver, evidenced
as a greater number of vacuoles (t = 2.924, p = 0.0192), sum of the vacuole area (t = 3.341, p =
0.0102); vacuole area as a percentage of the total vacuole area (t = 3.321, p = 0.0105), and larger
min Feret of the vacuoles (t = 2.326, p = 0.0485). Linear correlation showed the slope of the
BALB/c mice average vacuole size, perimeter, Feret, and min Feret vs. time were significantly
different from zero, suggesting a nanoceria-induced temporal effect. No significant linear
correlations were seen in C57BL/6 mice liver vacuole endpoints. ANOVA results of all liver
vacuole endpoints were significant at P < 0.0001 to 0.0003. Meaningful differences are a
significant increase in average vacuole size in C57BL/6 mice 0.5 h after nanoceria and between
C57BL/6 and BALB/c mice for all endpoints at various times after nanoceria (Supplemental
Figure 3). Spleen cell density was not different between the two mouse strains (t = 0.2574, p =
0.8033). C57BL/6 mice spleen cell density was not significantly affected by nanoceria (F(5,14) =
1.663, p =0.2080), but BALB/c mice spleen cell density was (F(5,14) = 6.008, p =0.0036).
Significant differences compared to the controls are shown in Table 1.
[Table 1 near here]
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Nanoceria Uptake and Bioprocessing at the Electron Microscopy Scale
Electron microscopy showed intracellular nanoceria particles in the liver as early as 0.5 h after
injection, presumably in phagolysosomes (Figure 4 A and B), surrounded by in situ formed
ferritin (biomineralized iron oxy hydroxide (FeHO2) (Figure 4 A to J). Elemental maps verify the
nanoceria identity and show association with phosphorus and iron (Figure 4 E2 to E5, F2 to F5,
H2 to H5, and J2 to J5). Light microscopic images obtained from same-treated mice can be seen
in Supplemental Figure 2.
[Figure 4 near here]
Within 0.5 h nanoceria bioprocessing had begun in the liver (Figure 5A to D). Cerium became
associated with phosphate to form crystalline cerium phosphate nanoneedles. EDS cerium and
cerium phosphate nanoneedle mapping showed epitaxial needle growth on nanoceria, where
some nanoceria typically remained at the center due to incomplete or limited transformation that
could be controlled by local environmental factors (Figure 5K and L). Electron diffractograms
obtained by focusing the electron beam on the needles where no nanoceria remained confirmed
that the crystalline nature of the in vivo formed Ce-phosphate phase corresponds to CePO4
(Figure 5B5, J4, and L4). Bioprocessing in the spleen resulted in cerium phosphate nanoneedles
that had the same size range. They were also identified as CePO4 (not shown).
[Figure 5 near here]
Nanoceria Induced Extensive Mouse-strain-dependent Ferritin Formation
STEM imaging revealed iron (ferritin) in lysosomes in close proximity to cerium-phosphate NPs.
This is seen as the EM bright ferritin spots near cerium-phosphate NP agglomerates which are in
the yellow squares (Figure 6B and C). Verification of cerium and iron was provided by EDS
(Figure 6D1), iron and oxygen by EDS elemental mapping (Figure 6D3 and D4), and cerium,
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phosphate, and iron by EDS mapping (Figure 6E1 to 3). The in situ formed crystalline cerium
phosphate nanoneedles were associated with a much greater accumulation of iron (ferritin)
particles in the region of nanoceria (red and yellow boxes) at 0.5 and 1 h (Figure 4A2, B2, C2,
and D2) and 24 h (Figure 6B and C) than normally present in cells (Figure 6A). EDS mapping
shows bioprocessed cerium phosphate needles occurring juxtaposed to ferritin (Figure 5A to D).
Ferritin particles surround the intact nanoceria and the in situ formed cerium phosphate
nanoneedles. Ferritin particle distribution in phagolysosomes was core-shell-like in C57BL/6
(Figure 6B and C) but evenly distributed in BALB/c mice (Figure 6E).
[Figure 6 near here]
EELS oxygen analysis of standard materials (amosite and hematite which contain only Fe++ and
Fe+++ respectively) were performed and the results compared to ferritin. EELS oxygen analysis
of amosite and hematite showed a pre-edge in the hematite but not in the amosite spectra (Figure
7A). EELS iron analysis showed a satellite peak in amosite but not hematite, and an ~ 1eV shift
towards higher voltage in hematite associated with Fe+++ (Figure 7B). EELS oxygen analysis
comparing the EM light (electron dense) ferritin spots in liver from C57BL/6 mice to hematite
showed an ~ 1/3 reduction of the oxygen pre-peak in ferritin (Figure 7 C). EELS iron analysis
comparing the ferritin spots in liver to hematite revealed a large pre-edge and a satellite peak in
ferritin that were absent in hematite, suggesting some Fe++. The ~ 1 eV shift to the right indicates
the presence of Fe+++ (Figure 7 D). These results show that the electron dense particles contain
oxygen and iron, predominantly as Fe+++, as stored in ferritin.
[Figure 7 near here]
Discussion
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The mice were exposed to nanoceria in this study via the i.p. route. This is not a typical route of
exposure for the human, but a common administration route in rodent studies and an effective
nanoceria administration route. The percent of the injection dose in the liver, spleen, kidneys,
lungs, heart, and brain (for both mouse strains over all times) was 12, 1.6, 0.78, 0.17, 0.03, and
0.003%, respectively. Injection of a similar-sized nanoceria by the same route resulted in a
similar ranking; spleen > liver > lung > kidney > heart > brain (Hirst et al. 2013). Nose-only 8
nm ceria exposure resulted in a similar kidney to liver cerium mass as the present study, 6%
(Guo et al. 2019). Intratracheal instillation of 6.6 nm ceria resulted in more cerium in the spleen
than the heart, kidneys, or brain, as the present study (He et al. 2010). Nanoceria uptake from the
peritoneal cavity resulted in similar cerium organ distribution to that following pulmonary
exposure of similar-sized nanoceria (Catalán et al. 2019). Intraperitoneally-administered
nanoceria has been reported to be beneficially effective to protect against radiation-induced
toxicity (Colon et al. 2010; Popov et al. 2016; Xu et al. 2016), hypoxia-induced lung damage
(Arya et al. 2013), ovarian cancer (Giri et al. 2013; Hijaz et al. 2016), lead-induced neurotoxicity
(Hosseini et al. 2015), chemically-induced hepatotoxicity (Adebayo et al. 2020; Amin et al.
2011; Amiri et al. 2018; Hashem et al. 2015), pancreatic damage (Khaksar et al. 2017), a model
of Parkinson’s disease (Hegazy et al. 2017), cardiotoxicity (Sangomla et al. 2018),
nephrotoxicity (Hamzeh et al. 2018; Saifi et al. 2019), testicular toxicity (Hamzeh et al. 2019),
psoriasis (Domala et al. 2020), streptozotocin-induced diabetes (Khurana et al. 2018; Pourkhalili
et al. 2011), and paraquat-induced brain oxidative stress (Domala et al. 2020; Ranjbar et al.
2018). Intraperitoneal nanoceria demonstrated anti-obesity activity (Rocca et al. 2015).
Nanoceria administration by this route has also been shown to produce liver and kidney toxicity
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(Negahdary et al. 2012; Poma et al. 2014) and male reproductive dysfunction (Adebayo et al.
2018).

Mouse strain-dependent nanoparticle uptake
We are aware of only one report of in vivo assessment of the effect of immune status on NP
uptake. Clearance from blood of NPs that were much larger (300 nm) than in this study (4 nm)
was more rapid in female BALB/c than C57BL/6 mice (Jones et al. 2013). Nanoparticle
concentration was much higher in liver and spleen than lung, heart, and kidney, as typically seen,
and initially (5 min to 2 h) higher in BALB/c than C57BL/6 mice liver and spleen. There was no
mouse strain difference at 24 h (Jones et al. 2013). In contrast, the present study showed more
cerium in C57BL/6 mice spleen over the five sampling times, and more in the liver at 24 h. The
significant decrease in brain cerium after 0.5 h is probably due to the decline in cerium in the
blood within the brain vasculature, as there is little evidence that nanomaterials significantly
enter brain parenchyma in the presence of an intact blood-brain barrier (Yokel 2020). The
present results and prior studies show rapid nanoceria uptake into organs after its introduction by
the intravenous (Molina et al. 2014; Rojas et al. 2012; Yokel et al. 2012; Yokel et al. 2009;
Yokel et al. 2013; Yokel et al. 2014), intratracheal (He et al. 2010), and gavage administration
routes (He et al. 2010), and the persistence of cerium for up to 5 months, some of which is the
administered nanoceria (He et al. 2010), suggesting little change would be expected in the
cerium concentration in these organs for weeks or more after nanoceria injection. Many variables
might be influencing the differences among the present and Jones et al results, including NP
physicochemical properties such as composition, size, shape, surface charge, surface area, and
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reactivity; and NP exposure and post-exposure durations. Mouse strain generally affected NP
uptake.

Nanoparticle-induced Caspase-1 Elevation
Prior studies do not provide clarity on the time course of post-insult caspase-1 elevation.
Caspase-1 elevation peaked within a few h in several murine and human cell lines (Liu et al.
2014; O'Brien et al. 2017), continued to increase over 8 h in human gingival epithelial cells (Bui
et al. 2016), peaked from 3 to 6 h in the small intestine of mice (Higashimori et al. 2016), but
peaked at 1 to 3 days in five cell types from the spleen of radiation-exposed mice (Stoecklein et
al. 2015). Caspase-1 elevation reversal, described in cells and animals, has been attributed to cell
death (O'Brien et al. 2017). The greater elevation of caspase-1 in BALB/c than C57BL/6 mice is
consistent with reported susceptibility of M2- vs M1-like cells to NP exposure. M2-polarized
murine macrophages showed greater proliferation reduction than M1-polarized cells in response
to 130 nm silica particle exposure (Herd et al. 2015). Similarly, viability decreased in M2-, but
not M1-polarized human monocyte-derived macrophages exposed to ~ 200 nm silica particles
(Gallud et al. 2017). The present results are consistent with those of (Herd et al. 2015) who found
greater NP uptake by M1-, than M2-like, murine macrophages and less toxicity, suggesting
polarization to the M1 phenotype provides a foreign matter coping mechanism (Herd et al.
2015).

Liver and Spleen Light Microscopic Mouse Strain and Nanoceria-treatment Differences
We are unaware of prior reports of more extensive liver vacuolation in C57BL/6 than BALB/c
mice, suggesting this is a novel finding. Increased vacuolation is generally considered an
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adaptive response, intended to limit damage (Henics and Wheatley 1999). C57BL/6 mice have
more macrophages activated toward an inflammatory response (M1) that may be consistent with
this finding. Increased vacuolation was attributed to osmotic effects associated with disturbed
ionic balance during nanoceria uptake (Shubin et al. 2016). Decreased vacuolation is presumably
due to a protective (anti-inflammatory/oxidative stress) nanoceria effect. This was seen in
BALB/c but not C57BL/6 mice, evidenced by significant reductions in liver average vacuole
size, perimeter, Feret, and min-Feret over time after nanoceria injection. Nanoceria increased
spleen lymphoid white pulp cell density (cells per area) in BALB/c but not C57BL/6 mice (Table
1), a response to chemical and stress insults (Elmore 2006; Vásquez et al. 2015).

Nanoceria Uptake and Bioprocessing at the Electron Microscopy Scale
Although originally considered very stable, some forms of nanoceria have been shown to
dissolve in an acidic, but not neutral, environment, given sufficient time to see the appearance of
cerium ions (Cornelis et al. 2011; Dahle et al. 2015; Yokel et al. 2019b) and in vivo, by
bioprocessing (Graham et al. 2014; Graham et al. 2017; Graham et al. 2018b). Cerium ions in the
presence of phosphate results in formation of cerium phosphate (Graham et al. 2017; Graham et
al. 2018b; Zhang et al. 2012), as was reported after i.p. injection of cerium ions and introduction
into the lung (Berry et al. 1989). The nanoneedles seen in C57BL/6 and BALB/c mice liver and
spleen were identical in form, shape, and size to those seen in human and murine (RAW 264.7)
macrophages polarized to M1 and M2 phenotypes (unpublished results). As Ce+++ and Ce++++
phosphate have been reported to be highly insoluble (log Ksp 10-26 to 10-23) (Lebedev and
Kulyako 1978; Liu and Byrne 1997) and (log Ksp 10-115 and 10-34) (Lebedev and Kulyako 1978;
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Li et al. 2005), respectively, the cerium phosphate nanoneedles are predicted to be very
persistent.

Ferritin accumulation at the site of nanoceria accumulation
There was a great increase of biomineralized oxygen- and iron-containing particles (~ 5 to 15 nm
iron-oxo particles) in the nanoceria-dosed compared to control mice (Figure 6). The presence of
oxygen and iron, in addition to a confined size and shape of ~5 to 12 nm spheroids, indicate
ferritin-like particles (Graham et al. 2020). The ~ 1/3 reduction of the oxygen edge in ferritin
from that seen in the standard hematite (toward the absence as seen in the standard amosite) and
the presence of a satellite peak in ferritin (as seen in amosite but not hematite) might be due to
several interpretations. They may be due to size or density differences in the highly crystalline
Fe2O3 (hematite) versus ferritin which contains protein (iron enters the protein channels and is
precipitated in the ferritin shell). Some Fe++ trapped inside the shell may not have been converted
to Fe+++. Also, the density of iron states in hematite may not be the same as ferritin iron.
Hydroxyl groups can be both electron-donating and electron-withdrawing, depending on whether
anti-bonding states are available. The hydroxyl group is electron-withdrawing through sigma
bonds and electron-donating through pi bonds, i.e., through anti-bonding states as compared to
the double bond to oxygen as in hematite. The results suggest a predominance of Fe+++ but some
Fe++ in the biomineralized oxygen- and iron-containing particles. Iron-oxo “ferritin” particles
typically form in protein cages made of ferritin-like protein subunits including dodecameric
“Dps”, encapsulins or icosahedra (Zeth et al. 2016). It is generally assumed that ferrous iron
(Fe++) binds the ferroxidase center and the oxidized iron (Fe+++) spontaneously enters the ferritin
cage through four channels that go through the protein shell and facilitate the influx and outflux
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of ions that control the formation iron-oxo precipitates. This biomineralization is catalyzed by
the presence of active ferroxidase centers lining the inside of the protein shell (Bradley et al.
2014). The formation of iron-oxo particles requires a series of steps including upregulation of
iron, oxidation, nucleation, biomineralization, and sequestration. The dense iron-oxo particles
can be seen in high-angle annular dark-field-STEM imaging. In the ferritin shell iron forms
crystallites of hydrous ferric oxide ferrihydrite with phosphorus present. Ferritin has been shown
to increase in response to stress, anoxia, infection, inﬂammation, trauma, surgery, tissue injury,
neoplastic growth, immunological disorders, and inflammatory cytokines in serum (NorthropClewes 2008; You and Wang 2005) and intracellularly (Beck et al. 2002; Larade and Storey
2004; You and Wang 2005). The main purpose of this acute phase protein response is as a
cellular defense mechanism to prevent further damage to the affected tissues and to remove
harmful molecules (Northrop-Clewes 2008). Induced ferritin protein and/or mRNA in cells has
been reported after exposure to sodium arsenite, H2O2, tert-butylhydroquinone, aqueous extract
of cigarette smoke, chemopreventive dithiolethiones, and 5 μm diameter silica particles (Bosio et
al. 2002; Ghio et al. 2019; Lee and Ho 1995; Pietsch et al. 2003; Tsuji et al. 2000). Intracellular
ferritin positively correlated with the extent of iron contamination in single-walled carbon
nanotubes (Cammisuli et al. 2018). Induction has also been seen in starfish following LPS
stimulation, in marine snail (periwinkle) hepatopancreas during anoxia, and the liver of rats that
received a glutathione-deleting agent (phorone), a chemoprotective agent (1,2-dithiole-3-thione),
or carbon tetrachloride (Beck et al. 2002; Cairo et al. 1995; Larade and Storey 2004; Primiano et
al. 1996; Schiaffonati and Tiberio 1997). Abnormal ferritin deposits containing ferritin protein
cages filled with iron-oxo NPs were seen in the globus pallidus of victims of an adult-onset basal
ganglia disease that has manifestations similar to Huntington’s disease or parkinsonism (Curtis et
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al. 2001) and lung of a Quebec asbestos mining region resident that demonstrated mesothelioma
(Graham et al. 2018a). It has been shown that invader NPs with various compositions or
structures delivered via different uptake routes (i.e., inhalation and i.v.), can share a common
response, specifically, the biomineralization of ferritin NPs (Graham et al. 2017). The
significance of iron in biological systems is, therefore, linked to its ability to engage in redox
reactions, including the scavenging of free radicals (Graham et al. 2014). Since the oxidation of
mobile Fe++ ions at ferroxidase centers leads to precipitated Fe+++, it is this catalytic process that
affords ferritin with its antioxidant property (Graham et al. 2020). The two studies of human
tissue and a study of liver from iron-loaded rats are the only reports we are aware of that showed
dense ferritin localization (Sorber et al. 1990). Mice liver ferritin density in the present study was
characterized by a close-arrangement and dense packing in phagolysosomes. The biomineralized
iron-oxo particles were clearly enriched in phagolysosomes, but only in those that also
harbored/contained invader nanoceria or its biotransformation product (cerium phosphate
nanoneedles). Compared to the very low ferritin density distribution in nanoceria-free tissue
(Figure 6A), the current HRTEM-study found select ceria-containing phagolysosomes that had
ferritin neighboring other ferritins with less than a couple nm space between the particles (Figure
6B-E). Particle density cannot be reliably assessed with the 2-dimensional (2D) imaging used in
the current study since phagolysosomes are 3D structures and we assume that the ferritin
particles distribute throughout the entire organelle. Therefore, to assess the ferritin density
distribution in mononuclear phagocytic system organs of C57BL/6 and BALB/c mice affected by
ceria, additional work using 3D reconstruction of ferritin containing phagolysosomes via electron
tomography will need to be performed in a follow-up study.
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Conclusions
The greater nanoceria uptake by mononuclear phagocytic system organs of C57BL/6 than
BALB/c mice may protect against nanoceria-induced effects. BALB/c mice were more
responsive to nanoceria-induced effects. They showed greater liver caspase-1 activation, reduced
liver vacuolation, and increased spleen cell density than C57BL/6 mice. Nanoceria was rapidly
taken up into phagolysosomes and underwent bioprocessing, including association with
phosphate and formation of crystalline cerium phosphate nanoneedles. There was a great
increase of ferritin that had a different distribution in C57BL/6 than BALB/c mice. Further study
will be needed to understand the mechanisms underlying the observed mouse strain differences.
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Table 1. Spleen differences due to mouse strain and nanoceria treatment, based on evaluation of
light microscopic images. * = Significantly different from control BALB/c mice.
Termination time
C57BL/6 mice
BALB/c mice
Spleen vacuolation differences: mouse strain and nanoceria - compared to vehicle-treated mice
0.5, 1, 3, 6, & 24 h
Not different from vacuolation in
Not different from vacuolation in
BALB/c mice
C57BL/6 mice
Spleen white pulp cell density: nanoceria-treated mice as a percent of vehicle-treated mice
0.5 h
106
105
1h
123
109
3h
107
132 *
6h
111
107 *
24 h
104
130 *
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Figure 1.
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Figure 1. Physicochemical properties of the as-dosed nanoceria. The as-dosed nanoceria is
shown in TEM images with increasing magnification as agglomerates on lacy carbon support (A,
B, C and D). E and G are STEM images at atomic resolution displaying rows of atoms (primary
particles are crystalline as indicated by d-spacings in E and G and the X-ray diffractogram in F
with characterisic ring structure signifying faces {100} and {111}). The surface of the primary
nanoceria has an increased defect density (lower atom density) as indicated by the yellow
squared areas in E and G. The EELS measurement in H was obtained at the nanoceria surface
inside the yellow squared area and the M5 and M4 Ce peaks at 883 eV and 901 eV, respectively,
are marked. The taller M5 peak indicates presence of predominantly Ce+++. The M5 peak is
missing a satellite peak (at 895 eV) which is characteristic of Ce+++ dominance. Ce+++ dominance
is caused by the increased defect density or oxygen vacancies in the nanoceria crystal surface.
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Figure 2.

Figure 2. Organ cerium as a percent of the injected dose. Results are mean ± S.D. of cerium,
determined by ICP-MS. They are expressed as a percent of the injected nanoceria dose, in the
whole organ, for the mouse strain, treatment and sacrifice times shown. Results are from five
control (vehicle treated) and three nanoceria-treated mice. + = Statistically different by
protected LSD. * = statistically different in two way ANOVA, at p < 0.05.
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Figure 3.

Figure 3. Liver caspase-1 levels. Results are mean ± S.D of 10 control (vehicle treated) mice and
six nanoceria-treated mice. *, **, ***, and *** indicate statistically significant differences at p <
0.05, 0.01, 0.001, and 0.0001, respectively.
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24 h

Figure 4. Nanoceria uptake in the liver of C57BL/6 and BALB/c mice at various times after
nanoceria injection. A1, A2, B1, B2, and C1 are TEM images. C2, D1, D2, E1, F1, G1, G2, H1,
I1, I2, and J1 are STEM images. 0.5, 1, 6, and 24 h indicate the time between nanoceria injection
and mouse termination. Intracellular nanoceria (Ce-NP, inside yellow circles and red squares) is
shown at 0.5 h (A and B), 1 h (C and D), 6 h (E and F), and 24 h (G to J). Nanoceria, which
occurs in agglomerates, looks dark in TEM and white in STEM imaging mode and is surrounded
by copious ferritin (Ferritin NP) accumulations (A2, B2, C2, D2, G2 and I2). Individual ferritin
nanoparticles are ~ 5 to 10 nm. Elemental maps (EDS mapping) are shown for corresponding
regions imaged in STEM mode and show verification of cerium and oxygen and co-localization
of cerium, oxygen, phosphorus, and iron after 6 h (Figure 4E1(STEM) with maps E2-5 and 4F1
(STEM) with maps 4F2-5) and after 24 h (Figure 4H1 (STEM) with maps 4H2-5 and 4J1
(STEM) with maps 4J2-5) after nanoceria injection.
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Figure 5.
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Figure 5. Nanoceria was bioprocessed in the liver. Examples of bioprocessed nanoceria 0.5, 6,
and 24 h after its injection are shown as STEM (A, C, G, and I) and TEM (E and K) images and
associated EDS elemental maps (B5, J4, and L4). The STEM images indicate the presence of
needles around the nanoceria. The nanoceria and needles in the STEM images are marked by
arrows and shown in the corresponding EDS maps as Ce, O, and P rich regions. Only the needles
are P-rich and are identified with X-ray diffraction pattern (B5 and L4) as Ce-phosphate. The
diffraction patterns also confirm the crystalline nature of the needles. The nanoceria are replaced
by Ce-phosphate during bioprocessing. The nanoceria and Ce-phosphate nanoneedles are
surrounded by copious ferritin nanoparticles (5A, C, G, I, and K) which are ~ 5 to 10 nm and are
identified in the corresponding EDS Fe maps (B4, D4, F4, H4, J3, and L3). Cellular regions that
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do not include nanoceria/Ce-phosphate have a very low density of ferritin while the ferritin
density around nanoceria/Ce-phosphate grains is significantly higher.
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Figure 6.
Normal biomineralized iron nanoparticle distribution

C57BL/6 mice
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Figure 6. Biomineralized iron nanoparticles (ferritin) accumulated in mouse liver after nanoceria
injection and occur in locally enriched zones around nanoceria. Biomineralized iron
nanoparticles are shown in the STEM images (A, B, and C) as white ~ 5 to 10 nm spots while the
nanoceria agglomerates are larger and denser (indicated in B and C with yellow squares).
Tissue regions that are not invaded by nanoceria have a low concentration or “normal”
distribution of ferritin (A). B and C are at 24 h post-nanoceria dosing. Both ferritin and
nanoceria associate with lysosomal regions or granules (B and C). Some granules are
completely filled with ferritin and nanoceria, while others appear to have a core-shell type
occupancy in the case of the C57BL/6 mice. Image D1 is an EDS spectrum identifying both Ce
and Fe and D2-4 are EDS maps obtained from the region defined by the red box in C. The
BALB/c mice liver uptake of nanoceria is shown in STEM images E1 to E2 which show EELS
mapping for Ce and P and a corresponding EDS map of Fe in E3 which indicates that iron
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accumulation as ferritin occurs in the vicinity of Ce-phosphate after bioprocessing of nanoceria
in the liver.

44

Figure 7.
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Figure 7. EELS oxygen and iron analyses of Fe++- and Fe+++-containing standard minerals
Amosite (Fe++) and Hematite (Fe+++) and the biomineralized iron nanoparticles (ferritin) that
accumulate around nanoceria in liver as shown in Figure 6 B and C. A shows the oxygen edge of
amosite (blue line) and hematite (red line) indicating a large edge in the Fe+++ (hematite) but not
Fe++- (amosite) containing standard. B shows the edge for iron with the standard materials
amosite (blue line) and hematite (red line) indicating a satellite peak for the Fe++- but not Fe+++containing standard mineral. There is also a slight energy shift of ~ 1 eV (B) to distinguish Fe++
versus Fe+++ rich phases. C shows the oxygen edge of ferritin that formed in the liver (green line)
and hematite standard (red line). The EELS comparison in C shows an ~ 1/3 reduction in the
oxygen edge of ferritin compared to the standard hematite. D illustrates the iron edge of ferritin
(green line) and hematite standard (red line) showing the presence of pre-edge and satellite peaks
in ferritin only and the alignment of the core edges of ferritin and hematite standard.
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Supplemental Figure 1. see separate file
Supplemental Figure 2. see separate file
Supplemental Figure 3. see separate file
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Supplemental Figure 1. Light microscopic images of liver from representative mice from each treatment
condition. All scale bars are 50 μm.
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Supplemental Figure 2. Light microscopic images of spleen from representative mice from each
treatment condition. All scale bars are 50 μm.
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Supplemental Figure 3. Liver vacuole endpoints in C57BL/6 and BALB/c mice as function of mouse strain and nanoceria
treatment. Results are the mean ± S.D. Significant difference by Tukey's multiple comparisons test, after significant
ANOVA, * = p < 0.05, ** = p < 0.01.

